Avita Medical is working with leading researchers and institutions in the field  of regenerative medicine and has more than 60 papers published in peer reviewed journals. Below is a selection of publications, to download the full bibliography please click here.

A randomized trial comparing ReCell® system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns.

STSG + RES™ v STSG RCT (n=88). Combination of RES™ + STSG grafting demonstrated significantly improved healing rates over STSG alone (41 versus 34; P=0.035). Time to healing in RES™ patients was significantly shorter (14 days versus 20 days) with a decrease in wound recurrence and complications

Preliminary results with the use of a non-cultured autologous cell suspension to repair non-healing vascular leg ulcers

Treatment of 12 ulcers (11 venous and 1 vasculitic) with RES™ resulted in a 55% mean reduction of the surface area of 10 ulcers and a complete healing of the remaining 2. These preliminary results demonstrate RES™ was effective in restarting the repair process of non-healing ulcers and in reducing pain


  1. Hu ZC, Chen D, Guo D, Liang YY, Zhang J, Zhu JY, Tang B. Randomized clinical trial of autologous skin cell suspension combined with skin grafting for chronic wounds. Br J Surg. 2015;102(2):e117-23.
  2. Giraldi E, Ricci E, Spreafico G, Baccaglini U. Preliminary results with the use of non-culturedautologous cell suspension to repair non-healing vascular ulcers. Acta Vulnologica. 2012. 10, 153-163.
  3. De Angelis B, Migner A, Lucarini L, Agovino A, Cervelli V. The use of a non-cultured autologous cell suspension to repair chronic ulcers Int Wound J 2013. 12(1):32-9.
  4. Trapasso M, Spagnolo F, Marchi F, Strada,P, Santi, P, Scala, M. Regenerative surgery for the definitive repair of a vasculitic non-healing ulcer using platelet-derived growth factors and non-cultured autologous cell suspension. Plast Reconstr Surg 2013; 1:1-3.
  5. Chant H, Woodrow T, Manley J Autologous skin cells: a new technique or skin regeneration in diabetic and vascular ulcers. Journal of Wound Care 2013;22(10Suppl):S10-5.
  6. Using ReCell® to Treat Difficult to Heal Chronic Wounds Case Study Jeremy RawlinsFRCS(Plast), Consultant Plastic Surgeon.
  7. Personal communication with Paul Hayes, lead principal investigator, ongoing Pilot Randomized Controlled Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers.
  8. Company data, Avita Medical VLU chronic wounds health economic analysis v5, available on request
  9. Singer AJ, Clark RAF. Cutaneuous wound healing. New England Journal of Medicine 1999; 341(10):739-746.